Global Psoriasis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Psoriasis Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Psoriasis Therapeutics industry chain, the market status of Oral (TNF Inhibitors, PDE4 Inhibitors), Parenteral (TNF Inhibitors, PDE4 Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Psoriasis Therapeutics.
Regionally, the report analyzes the Psoriasis Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Psoriasis Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Psoriasis Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Psoriasis Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., TNF Inhibitors, PDE4 Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Psoriasis Therapeutics market.
Regional Analysis: The report involves examining the Psoriasis Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Psoriasis Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Psoriasis Therapeutics:
Company Analysis: Report covers individual Psoriasis Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Psoriasis Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral, Parenteral).
Technology Analysis: Report covers specific technologies relevant to Psoriasis Therapeutics. It assesses the current state, advancements, and potential future developments in Psoriasis Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Psoriasis Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Psoriasis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Psoriasis Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Psoriasis Therapeutics, with revenue, gross margin and global market share of Psoriasis Therapeutics from 2019 to 2024.
Chapter 3, the Psoriasis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Psoriasis Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Psoriasis Therapeutics.
Chapter 13, to describe Psoriasis Therapeutics research findings and conclusion.
Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Psoriasis Therapeutics industry chain, the market status of Oral (TNF Inhibitors, PDE4 Inhibitors), Parenteral (TNF Inhibitors, PDE4 Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Psoriasis Therapeutics.
Regionally, the report analyzes the Psoriasis Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Psoriasis Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Psoriasis Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Psoriasis Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., TNF Inhibitors, PDE4 Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Psoriasis Therapeutics market.
Regional Analysis: The report involves examining the Psoriasis Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Psoriasis Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Psoriasis Therapeutics:
Company Analysis: Report covers individual Psoriasis Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Psoriasis Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral, Parenteral).
Technology Analysis: Report covers specific technologies relevant to Psoriasis Therapeutics. It assesses the current state, advancements, and potential future developments in Psoriasis Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Psoriasis Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Psoriasis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- TNF Inhibitors
- PDE4 Inhibitors
- Interleukin Blockers
- Others
- Oral
- Parenteral
- Topical
- Astellas Pharma Inc.
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- F. Hofffmann-La Roche
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Valeant Pharmaceuticals International, Inc.
- Biocon Limited
- Eli Lilly and Company
- G & W Laboratories Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Psoriasis Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Psoriasis Therapeutics, with revenue, gross margin and global market share of Psoriasis Therapeutics from 2019 to 2024.
Chapter 3, the Psoriasis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Psoriasis Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Psoriasis Therapeutics.
Chapter 13, to describe Psoriasis Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Psoriasis Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Psoriasis Therapeutics by Type
1.3.1 Overview: Global Psoriasis Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Psoriasis Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 TNF Inhibitors
1.3.4 PDE4 Inhibitors
1.3.5 Interleukin Blockers
1.3.6 Others
1.4 Global Psoriasis Therapeutics Market by Application
1.4.1 Overview: Global Psoriasis Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral
1.4.3 Parenteral
1.4.4 Topical
1.5 Global Psoriasis Therapeutics Market Size & Forecast
1.6 Global Psoriasis Therapeutics Market Size and Forecast by Region
1.6.1 Global Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Psoriasis Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Psoriasis Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions
2.1.4 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.2 AstraZeneca plc
2.2.1 AstraZeneca plc Details
2.2.2 AstraZeneca plc Major Business
2.2.3 AstraZeneca plc Psoriasis Therapeutics Product and Solutions
2.2.4 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca plc Recent Developments and Future Plans
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions
2.3.4 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.4 F. Hofffmann-La Roche
2.4.1 F. Hofffmann-La Roche Details
2.4.2 F. Hofffmann-La Roche Major Business
2.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions
2.4.4 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hofffmann-La Roche Recent Developments and Future Plans
2.5 GlaxoSmithKline plc
2.5.1 GlaxoSmithKline plc Details
2.5.2 GlaxoSmithKline plc Major Business
2.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business
2.6.3 Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions
2.6.4 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Merck & Co., Inc. Recent Developments and Future Plans
2.7 Valeant Pharmaceuticals International, Inc.
2.7.1 Valeant Pharmaceuticals International, Inc. Details
2.7.2 Valeant Pharmaceuticals International, Inc. Major Business
2.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions
2.7.4 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans
2.8 Biocon Limited
2.8.1 Biocon Limited Details
2.8.2 Biocon Limited Major Business
2.8.3 Biocon Limited Psoriasis Therapeutics Product and Solutions
2.8.4 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biocon Limited Recent Developments and Future Plans
2.9 Eli Lilly and Company
2.9.1 Eli Lilly and Company Details
2.9.2 Eli Lilly and Company Major Business
2.9.3 Eli Lilly and Company Psoriasis Therapeutics Product and Solutions
2.9.4 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly and Company Recent Developments and Future Plans
2.10 G & W Laboratories Inc.
2.10.1 G & W Laboratories Inc. Details
2.10.2 G & W Laboratories Inc. Major Business
2.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions
2.10.4 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 G & W Laboratories Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Psoriasis Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Psoriasis Therapeutics by Company Revenue
3.2.2 Top 3 Psoriasis Therapeutics Players Market Share in 2023
3.2.3 Top 6 Psoriasis Therapeutics Players Market Share in 2023
3.3 Psoriasis Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Psoriasis Therapeutics Market: Region Footprint
3.3.2 Psoriasis Therapeutics Market: Company Product Type Footprint
3.3.3 Psoriasis Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Psoriasis Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Psoriasis Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Psoriasis Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Psoriasis Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Psoriasis Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Psoriasis Therapeutics Market Size by Country
6.3.1 North America Psoriasis Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Psoriasis Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Psoriasis Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Psoriasis Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Psoriasis Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Psoriasis Therapeutics Market Size by Country
7.3.1 Europe Psoriasis Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Psoriasis Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Psoriasis Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region
8.3.1 Asia-Pacific Psoriasis Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Psoriasis Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Psoriasis Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Psoriasis Therapeutics Market Size by Country
9.3.1 South America Psoriasis Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Psoriasis Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Psoriasis Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Psoriasis Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country
10.3.1 Middle East & Africa Psoriasis Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Psoriasis Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Psoriasis Therapeutics Market Drivers
11.2 Psoriasis Therapeutics Market Restraints
11.3 Psoriasis Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Psoriasis Therapeutics Industry Chain
12.2 Psoriasis Therapeutics Upstream Analysis
12.3 Psoriasis Therapeutics Midstream Analysis
12.4 Psoriasis Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Psoriasis Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Psoriasis Therapeutics by Type
1.3.1 Overview: Global Psoriasis Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Psoriasis Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 TNF Inhibitors
1.3.4 PDE4 Inhibitors
1.3.5 Interleukin Blockers
1.3.6 Others
1.4 Global Psoriasis Therapeutics Market by Application
1.4.1 Overview: Global Psoriasis Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral
1.4.3 Parenteral
1.4.4 Topical
1.5 Global Psoriasis Therapeutics Market Size & Forecast
1.6 Global Psoriasis Therapeutics Market Size and Forecast by Region
1.6.1 Global Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Psoriasis Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Psoriasis Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Psoriasis Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions
2.1.4 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.2 AstraZeneca plc
2.2.1 AstraZeneca plc Details
2.2.2 AstraZeneca plc Major Business
2.2.3 AstraZeneca plc Psoriasis Therapeutics Product and Solutions
2.2.4 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca plc Recent Developments and Future Plans
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions
2.3.4 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.4 F. Hofffmann-La Roche
2.4.1 F. Hofffmann-La Roche Details
2.4.2 F. Hofffmann-La Roche Major Business
2.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions
2.4.4 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hofffmann-La Roche Recent Developments and Future Plans
2.5 GlaxoSmithKline plc
2.5.1 GlaxoSmithKline plc Details
2.5.2 GlaxoSmithKline plc Major Business
2.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business
2.6.3 Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions
2.6.4 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Merck & Co., Inc. Recent Developments and Future Plans
2.7 Valeant Pharmaceuticals International, Inc.
2.7.1 Valeant Pharmaceuticals International, Inc. Details
2.7.2 Valeant Pharmaceuticals International, Inc. Major Business
2.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions
2.7.4 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans
2.8 Biocon Limited
2.8.1 Biocon Limited Details
2.8.2 Biocon Limited Major Business
2.8.3 Biocon Limited Psoriasis Therapeutics Product and Solutions
2.8.4 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biocon Limited Recent Developments and Future Plans
2.9 Eli Lilly and Company
2.9.1 Eli Lilly and Company Details
2.9.2 Eli Lilly and Company Major Business
2.9.3 Eli Lilly and Company Psoriasis Therapeutics Product and Solutions
2.9.4 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly and Company Recent Developments and Future Plans
2.10 G & W Laboratories Inc.
2.10.1 G & W Laboratories Inc. Details
2.10.2 G & W Laboratories Inc. Major Business
2.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions
2.10.4 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 G & W Laboratories Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Psoriasis Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Psoriasis Therapeutics by Company Revenue
3.2.2 Top 3 Psoriasis Therapeutics Players Market Share in 2023
3.2.3 Top 6 Psoriasis Therapeutics Players Market Share in 2023
3.3 Psoriasis Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Psoriasis Therapeutics Market: Region Footprint
3.3.2 Psoriasis Therapeutics Market: Company Product Type Footprint
3.3.3 Psoriasis Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Psoriasis Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Psoriasis Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Psoriasis Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Psoriasis Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Psoriasis Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Psoriasis Therapeutics Market Size by Country
6.3.1 North America Psoriasis Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Psoriasis Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Psoriasis Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Psoriasis Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Psoriasis Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Psoriasis Therapeutics Market Size by Country
7.3.1 Europe Psoriasis Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Psoriasis Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Psoriasis Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region
8.3.1 Asia-Pacific Psoriasis Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Psoriasis Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Psoriasis Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Psoriasis Therapeutics Market Size by Country
9.3.1 South America Psoriasis Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Psoriasis Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Psoriasis Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Psoriasis Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country
10.3.1 Middle East & Africa Psoriasis Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Psoriasis Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Psoriasis Therapeutics Market Drivers
11.2 Psoriasis Therapeutics Market Restraints
11.3 Psoriasis Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Psoriasis Therapeutics Industry Chain
12.2 Psoriasis Therapeutics Upstream Analysis
12.3 Psoriasis Therapeutics Midstream Analysis
12.4 Psoriasis Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Psoriasis Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Psoriasis Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Psoriasis Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Psoriasis Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
Table 6. Astellas Pharma Inc. Major Business
Table 7. Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions
Table 8. Astellas Pharma Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Astellas Pharma Inc. Recent Developments and Future Plans
Table 10. AstraZeneca plc Company Information, Head Office, and Major Competitors
Table 11. AstraZeneca plc Major Business
Table 12. AstraZeneca plc Psoriasis Therapeutics Product and Solutions
Table 13. AstraZeneca plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. AstraZeneca plc Recent Developments and Future Plans
Table 15. Boehringer Ingelheim GmbH Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim GmbH Major Business
Table 17. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions
Table 18. Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Table 20. F. Hofffmann-La Roche Company Information, Head Office, and Major Competitors
Table 21. F. Hofffmann-La Roche Major Business
Table 22. F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions
Table 23. F. Hofffmann-La Roche Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. F. Hofffmann-La Roche Recent Developments and Future Plans
Table 25. GlaxoSmithKline plc Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline plc Major Business
Table 27. GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions
Table 28. GlaxoSmithKline plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline plc Recent Developments and Future Plans
Table 30. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 31. Merck & Co., Inc. Major Business
Table 32. Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions
Table 33. Merck & Co., Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Merck & Co., Inc. Recent Developments and Future Plans
Table 35. Valeant Pharmaceuticals International, Inc. Company Information, Head Office, and Major Competitors
Table 36. Valeant Pharmaceuticals International, Inc. Major Business
Table 37. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions
Table 38. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans
Table 40. Biocon Limited Company Information, Head Office, and Major Competitors
Table 41. Biocon Limited Major Business
Table 42. Biocon Limited Psoriasis Therapeutics Product and Solutions
Table 43. Biocon Limited Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Biocon Limited Recent Developments and Future Plans
Table 45. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly and Company Major Business
Table 47. Eli Lilly and Company Psoriasis Therapeutics Product and Solutions
Table 48. Eli Lilly and Company Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly and Company Recent Developments and Future Plans
Table 50. G & W Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 51. G & W Laboratories Inc. Major Business
Table 52. G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions
Table 53. G & W Laboratories Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. G & W Laboratories Inc. Recent Developments and Future Plans
Table 55. Global Psoriasis Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Psoriasis Therapeutics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Psoriasis Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Psoriasis Therapeutics Players
Table 60. Psoriasis Therapeutics Market: Company Product Type Footprint
Table 61. Psoriasis Therapeutics Market: Company Product Application Footprint
Table 62. Psoriasis Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. Psoriasis Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Psoriasis Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Psoriasis Therapeutics Consumption Value Share by Type (2019-2024)
Table 66. Global Psoriasis Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Psoriasis Therapeutics Consumption Value by Application (2019-2024)
Table 68. Global Psoriasis Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Psoriasis Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Psoriasis Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Psoriasis Therapeutics Raw Material
Table 100. Key Suppliers of Psoriasis Therapeutics Raw Materials
Table 1. Global Psoriasis Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Psoriasis Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Psoriasis Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Psoriasis Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
Table 6. Astellas Pharma Inc. Major Business
Table 7. Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions
Table 8. Astellas Pharma Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Astellas Pharma Inc. Recent Developments and Future Plans
Table 10. AstraZeneca plc Company Information, Head Office, and Major Competitors
Table 11. AstraZeneca plc Major Business
Table 12. AstraZeneca plc Psoriasis Therapeutics Product and Solutions
Table 13. AstraZeneca plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. AstraZeneca plc Recent Developments and Future Plans
Table 15. Boehringer Ingelheim GmbH Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim GmbH Major Business
Table 17. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions
Table 18. Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Table 20. F. Hofffmann-La Roche Company Information, Head Office, and Major Competitors
Table 21. F. Hofffmann-La Roche Major Business
Table 22. F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions
Table 23. F. Hofffmann-La Roche Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. F. Hofffmann-La Roche Recent Developments and Future Plans
Table 25. GlaxoSmithKline plc Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline plc Major Business
Table 27. GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions
Table 28. GlaxoSmithKline plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline plc Recent Developments and Future Plans
Table 30. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 31. Merck & Co., Inc. Major Business
Table 32. Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions
Table 33. Merck & Co., Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Merck & Co., Inc. Recent Developments and Future Plans
Table 35. Valeant Pharmaceuticals International, Inc. Company Information, Head Office, and Major Competitors
Table 36. Valeant Pharmaceuticals International, Inc. Major Business
Table 37. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions
Table 38. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans
Table 40. Biocon Limited Company Information, Head Office, and Major Competitors
Table 41. Biocon Limited Major Business
Table 42. Biocon Limited Psoriasis Therapeutics Product and Solutions
Table 43. Biocon Limited Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Biocon Limited Recent Developments and Future Plans
Table 45. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly and Company Major Business
Table 47. Eli Lilly and Company Psoriasis Therapeutics Product and Solutions
Table 48. Eli Lilly and Company Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly and Company Recent Developments and Future Plans
Table 50. G & W Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 51. G & W Laboratories Inc. Major Business
Table 52. G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions
Table 53. G & W Laboratories Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. G & W Laboratories Inc. Recent Developments and Future Plans
Table 55. Global Psoriasis Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Psoriasis Therapeutics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Psoriasis Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Psoriasis Therapeutics Players
Table 60. Psoriasis Therapeutics Market: Company Product Type Footprint
Table 61. Psoriasis Therapeutics Market: Company Product Application Footprint
Table 62. Psoriasis Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. Psoriasis Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Psoriasis Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Psoriasis Therapeutics Consumption Value Share by Type (2019-2024)
Table 66. Global Psoriasis Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Psoriasis Therapeutics Consumption Value by Application (2019-2024)
Table 68. Global Psoriasis Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Psoriasis Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Psoriasis Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Psoriasis Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Psoriasis Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Psoriasis Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Psoriasis Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Psoriasis Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Psoriasis Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Psoriasis Therapeutics Raw Material
Table 100. Key Suppliers of Psoriasis Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Psoriasis Therapeutics Picture
Figure 2. Global Psoriasis Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Psoriasis Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. TNF Inhibitors
Figure 5. PDE4 Inhibitors
Figure 6. Interleukin Blockers
Figure 7. Others
Figure 8. Global Psoriasis Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Psoriasis Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Oral Picture
Figure 11. Parenteral Picture
Figure 12. Topical Picture
Figure 13. Global Psoriasis Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Psoriasis Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Psoriasis Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Psoriasis Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Psoriasis Therapeutics Consumption Value Market Share by Region in 2023
Figure 18. North America Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Psoriasis Therapeutics Revenue Share by Players in 2023
Figure 24. Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Psoriasis Therapeutics Market Share in 2023
Figure 26. Global Top 6 Players Psoriasis Therapeutics Market Share in 2023
Figure 27. Global Psoriasis Therapeutics Consumption Value Share by Type (2019-2024)
Figure 28. Global Psoriasis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 29. Global Psoriasis Therapeutics Consumption Value Share by Application (2019-2024)
Figure 30. Global Psoriasis Therapeutics Market Share Forecast by Application (2025-2030)
Figure 31. North America Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Psoriasis Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Psoriasis Therapeutics Market Drivers
Figure 66. Psoriasis Therapeutics Market Restraints
Figure 67. Psoriasis Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Psoriasis Therapeutics in 2023
Figure 70. Manufacturing Process Analysis of Psoriasis Therapeutics
Figure 71. Psoriasis Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Psoriasis Therapeutics Picture
Figure 2. Global Psoriasis Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Psoriasis Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. TNF Inhibitors
Figure 5. PDE4 Inhibitors
Figure 6. Interleukin Blockers
Figure 7. Others
Figure 8. Global Psoriasis Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Psoriasis Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Oral Picture
Figure 11. Parenteral Picture
Figure 12. Topical Picture
Figure 13. Global Psoriasis Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Psoriasis Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Psoriasis Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Psoriasis Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Psoriasis Therapeutics Consumption Value Market Share by Region in 2023
Figure 18. North America Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Psoriasis Therapeutics Revenue Share by Players in 2023
Figure 24. Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Psoriasis Therapeutics Market Share in 2023
Figure 26. Global Top 6 Players Psoriasis Therapeutics Market Share in 2023
Figure 27. Global Psoriasis Therapeutics Consumption Value Share by Type (2019-2024)
Figure 28. Global Psoriasis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 29. Global Psoriasis Therapeutics Consumption Value Share by Application (2019-2024)
Figure 30. Global Psoriasis Therapeutics Market Share Forecast by Application (2025-2030)
Figure 31. North America Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Psoriasis Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Psoriasis Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Psoriasis Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Psoriasis Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Psoriasis Therapeutics Market Drivers
Figure 66. Psoriasis Therapeutics Market Restraints
Figure 67. Psoriasis Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Psoriasis Therapeutics in 2023
Figure 70. Manufacturing Process Analysis of Psoriasis Therapeutics
Figure 71. Psoriasis Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
